Role of campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: An update

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Nyati, Kishan Kumar ^a   Nyati, Roopanshi ^b  

^a OSAKA UNIVERSITY   (Japan)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CORTICOSTEROID; EPITOPE; ERYTHROMYCIN; GANGLIOSIDE; HOST FACTOR; IMMUNOGLOBULIN; INFLUENZA VACCINE; LIPOOLIGOSACCHARIDE; QUINOLONE DERIVATIVE;

AUTOIMMUNITY; BACTERIAL MEMBRANE; BACTERIUM DETECTION; BACTERIUM ISOLATION; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CARBOHYDRATE ANALYSIS; CORTICOSTEROID THERAPY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; GUILLAIN BARRE SYNDROME; HOST; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA VACCINATION; LYMPHOCYTE TRANSFORMATION TEST; MILK; MOLECULAR MIMICRY; NERVE INJURY; NONHUMAN; PATHOGENESIS; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; POULTRY; REVIEW; RISK ASSESSMENT; VACCINATION; WATER CONTAMINATION; ANIMAL; CAMPYLOBACTERIOSIS; EPIDEMIOLOGY; IMMUNOLOGY; MICROBIOLOGY; PERIPHERAL NERVE; CAUSALITY; COMPLICATION; GUILLAIN-BARRE SYNDROME;

ANIMALS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CAUSALITY; GUILLAIN-BARRE SYNDROME; HUMANS; PERIPHERAL NERVES;

EID: 84884274574     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/852195     Document Type: Review

References (127)

1. Asbury A. K., Cornblath D. R., Assessment of current diagnostic criteria for Guillain-Barre syndrome. Annals of Neurology 1990 27 S21 S24 2-s2.0-0025375133 10.1002/ana.410270707
2. Kuwabara S., Guillain-Barré syndrome: epidemiology, pathophysiology and management. Drugs 2004 64 6 597 610 2-s2.0-1842784961 10.2165/00003495-200464060-00003
3. Vucic S., Kiernan M. C., Cornblath D. R., Guillain-Barré syndrome: an update. Journal of Clinical Neuroscience 2009 16 6 733 741 2-s2.0-67349199109 10.1016/j.jocn.2008.08.033
4. Sinha S., Prasad K. N., Pradhan S., Jain D., Jha S., Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome. Transactions of the Royal Society of Tropical Medicine and Hygiene 2004 98 6 342 346 2-s2.0-3042739122 10.1016/j.trstmh.2003.10.007
5. Sinha S., Prasad K. N., Jain D., Nyati K. K., Pradhan S., Agrawal S., Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barré syndrome. Acta Neurologica Scandinavica 2010 122 1 21 26 2-s2.0-77953337798 10.1111/j.1600-0404.2009.01229.x
6. Nyati K. K., Prasad K. N., Rizwan A., Verma A., Paliwal V. K., TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barré syndrome. Archives of Neurology 2011 68 4 445 452 2-s2.0-79953894884 10.1001/archneurol. 2011.51
7. Godschalk P. C. R., Heikema A. P., Gilbert M., Komagamine T., Wim Ang C., Glerum J., Brochu D., Li J., Yuki N., Jacobs B. C., Van Belkum A., Endtz H. P., The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome. Journal of Clinical Investigation 2004 114 11 1659 1665 2-s2.0-14644435916 10.1172/JCI200415707
8. Nachamkin I., Liu J., Li M., Ung H., Moran A. P., Prendergast M. M., Sheikh K., Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD1a-like epitope. Infection and Immunity 2002 70 9 5299 5303 2-s2.0-0036718373 10.1128/IAI.70.9.5299-5303.2002
9. Mishu B., Blaser M. J., Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barre syndrome. Clinical Infectious Diseases 1993 17 1 104 108 2-s2.0-0027253055
10. Allos B. M., Association between Campylobacter infection and Guillain-Barre syndrome. Journal of Infectious Diseases 1997 176 6 S125 S128 2-s2.0-0030716782
11. Kaldor J., Speed B. R., Guillain-Barre syndrome and Campylobacter jejuni: a serological study. British Medical Journal 1984 288 6434 1867 1870 2-s2.0-0021254874
12. Magira E. E., Papaioakim M., Nachamkin I., Asbury A. K., Li C. Y., Ho T. W., Griffin J. W., McKhann G. M., Monos D. S., Differential distribution of HLA-DQ β /DR β epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ β epitopes associated with susceptibility to and protection from AIDP. Journal of Immunology 2003 170 6 3074 3080 2-s2.0-0347927276
13. Ho T. W., Mishu B., Li C. Y., Gao C. Y., Cornblath D. R., Griffin J. W., Asbury A. K., Blaser M. J., McKhann G. M., Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995 118 3 597 605 2-s2.0-0029017652
14. Koski C. L., Mechanisms of Schwann cell damage in inflammatory neuropathy. Journal of Infectious Diseases 1997 176 6 S169 S172 2-s2.0-0030661573
15. Griffin J. W., Li C. Y., Ho T. W., Tian M., Gao C. Y., Xue P., Mishu B., Cornblath D. R., Macko C., McKhann G. M., Asbury A. K., Pathology of the motor-sensory axonal guillain-barré syndrome. Annals of Neurology 1996 39 1 17 28 2-s2.0-0030065669
16. Hughes R. A. C., Rees J. H., Clinical and epidemiologic features of Guillain-Barre syndrome. Journal of Infectious Diseases 1997 176 6 S92 S98 2-s2.0-0030723101
17. Nyati K. K., Prasad K. N., Verma A., Singh A. K., Rizwan A., Sinha S., Paliwal V. K., Pradhan S., Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population. Journal of Neuroimmunology 2010 218 1-2 116 119 2-s2.0-73149094059 10.1016/j.jneuroim.2009.10.018
18. Griffin J. W., Li C. Y., Ho T. W., Xue P., Macko C., Gao C. Y., Yang C., Tian M., Mishu B., Cornblath D. R., Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995 118 3 577 595 2-s2.0-0029314524
19. Yuki N., Pathogenesis of axonal Guillain-Barre syndrome: hypothesis. Muscle & Nerve 1994 17 6 680 682 2-s2.0-0028360951 10.1002/mus.880170619
20. Ogawara K., Kuwabara S., Mori M., Hattori T., Koga M., Yuki N., Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Annals of Neurology 2000 48 4 624 631 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O
21. Enders U., Karch H., Toyka K. V., Michels M., Zielasek J., Pette M., Heesemann J., Hartung H.-P., The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barre syndrome and in other neuroimmunological disorders. Annals of Neurology 1993 34 2 136 144 2-s2.0-0027328986
22. Nyati K. K., Prasad K. N., Kharwar N. K., Soni P., Husain N., Agrawal V., Jain A. K., Immunopathology and Th1/Th2 immune response of Campylobacter jejuni -induced paralysis resembling Guillain-Barré syndrome in chicken. Medical Microbiology and Immunology 2012 201 2 177 187 2-s2.0-81555232274 10.1007/s00430-011-0220-3
23. Jacobs B. C., van Doorn P. A., Schmitz P. I. M., Tio-Gillen A. P., Herbrink P., Visser L. H., Hooijkaas H., van der Meché F. G. A., Campylobacter jejuni infections and anti-GM1 antibodies in Guillain- Barre syndrome. Annals of Neurology 1996 40 2 181 187 2-s2.0-0029841961
24. Rees J. H., Gregson N. A., Hughes R. A. C., Anti-ganglioside GM1 antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection. Annals of Neurology 1995 38 5 809 816 2-s2.0-0028972022 10.1002/ana.410380516
25. Vriesendorp F. J., Mishu B., Blaser M. J., Koski C. L., Fishman R. A., Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barre syndrome and controls: correlation and prognosis. Annals of Neurology 1993 34 2 130 135 2-s2.0-0027176630
26. Mead P. S., Slutsker L., Dietz V., McCaig L. F., Bresee J. S., Shapiro C., Griffin P. M., Tauxe R. V., Food-related illness and death in the United States. Emerging Infectious Diseases 1999 5 5 607 625 2-s2.0-0032694976
27. Friedman C. R., Neimann J., Wegener H. C., Tauxe R. V., Nachamkin I., Blaser M. J., Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. Campylobacter 2000 2nd Washington, DC, USA ASM Press 121 138
28. McKhann G. M., Cornblath D. R., Griffin J. W., Ho T. W., Li C. Y., Jiang Z., Wu H. S., Zhaori G., Liu Y., Jou L. P., Liu T. C., Gao C. Y., Mao J. Y., Blaser M. J., Mishu B., Asbury A. K., Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Annals of Neurology 1993 33 4 333 342 2-s2.0-0027526381
29. Ramos-Alvarez M., Bessudo L., Sabin A. B., Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome. Journal of the American Medical Association 1969 207 8 1481 1492 2-s2.0-0014689108
30. Valenciano L., Nájera E., Gallardo F. P., González A., Enrech J., Outbreak of paralytic illness of unknown etiology in albacete, Spain. American Journal of Epidemiology 1971 94 5 450 456 2-s2.0-0015152075
31. Kuroki S., Saida T., Nukina M., Haruta T., Yoshioka M., Kobayashi Y., Nakanishi H., Campylobacter jejuni strains from patients with Guillain-Barre syndrome belong mostly to Penner serogroup 19 and contain β -N-acetylglucosamine residues. Annals of Neurology 1993 33 3 243 247 2-s2.0-0027417971
32. Rees J. H., Soudain S. E., Gregson N. A., Hughes R. A. C., Campylobacter jejuni infection and Guillain-Barre syndrome. New England Journal of Medicine 1995 333 21 1374 1379 2-s2.0-0028798975 10.1056/NEJM199511233332102
33. Ropper A. H., Campylobacter diarrhea and Guillain-Barre syndrome. Archives of Neurology 1988 45 6 655 656 2-s2.0-0023917198
34. Prasad K. N., Pradhan S., Nag V. L., Guillain-Barre syndrome and Campylobacter infection. Southeast Asian Journal of Tropical Medicine and Public Health 2001 32 3 527 530 2-s2.0-0035469491
35. Nyati K. K., Prasad K. N., Rizwan A., Verma A., Paliwal V. K., Pradhan S., Lymphocyte transformation test detects a response to Campylobacter jejuni antigens in patients with Guillain-Barré syndrome. Medical Microbiology and Immunology 2010 199 2 109 116 2-s2.0-77953284699 10.1007/s00430-010-0144-3
36. Nachamkin I., Allos B. M., Ho T., Campylobacter species and Guillain-Barre syndrome. Clinical Microbiology Reviews 1998 11 3 555 567 2-s2.0-0031852829
37. Young K. T., Davis L. M., DiRita V. J., Campylobacter jejuni: molecular biology and pathogenesis. Nature Reviews Microbiology 2007 5 9 665 679 2-s2.0-34548028239 10.1038/nrmicro1718
38. Miljkovic-Selimovic B., Lavrnic D., Morić O., Ng L. K., Price L., Suturkova L., Kocic B., Babić T., Ristić L., Apostolski S., Enteritis caused by Campylobacter jejuni followed by acute motor axonal neuropathy: a case report. Journal of Medical Case Reports 2010 4 article 101
39. Li C. Y., Xue P., Tian W. Q., Liu R. C., Yang C., Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. Journal of Neurology Neurosurgery and Psychiatry 1996 61 3 279 284 2-s2.0-0029810715
40. Rhodes K. M., Tattersfield A. E., Guillain-Barre syndrome associated with Campylobacter infection. British Medical Journal 1982 285 6336 173 174 2-s2.0-0019976185
41. Constant O. C., Bentley C. C., Denman A. M., The Guillain-Barre syndrome following Campylobacter enteritis with recovery after plasmapheresis. Journal of Infection 1983 6 1 89 91 2-s2.0-0020647499
42. Molnar G. K., Mertsola J., Erkko M., Guillain-Barré syndrome associated with campylobacter infection. British Medical Journal 1982 285 6342 652 2-s2.0-0020492898
43. Pryor W. M., Freiman J. S., Gillies M. A., Tuck R. R., Guillain-Barré syndrome associated with Campylobacter infection. Australian and New Zealand Journal of Medicine 1984 14 5 687 688 2-s2.0-0021511867
44. Speed B. R., Kaldor J., Guillain-Barré syndrome associated with Campylobacter infection. Australian and New Zealand Journal of Medicine 1985 15 2, article 269 2-s2.0-0022040740
45. Sinha S., Prasad K. N., Jain D., Pandey C. M., Jha S., Pradhan S., Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barrésyndrome: a single centre prospective case-control study. Clinical Microbiology and Infection 2007 13 3 334 337 2-s2.0-34247252563 10.1111/j.1469-0691.2006.01636.x
46. Hadden R. D. M., Karch H., Hartung H.-P., Zielasek J., Weissbrich B., Schubert J., Weishaupt A., Cornblath D. R., Swan A. V., Hughes R. A. C., Toyka K. V., Preceding infections, immune factors, and outcome in Guillain- Barré syndrome. Neurology 2001 56 6 758 765 2-s2.0-0035957291
47. Allos B. M., Lippy F. T., Carlsen A., Washburn R. G., Blaser M. J., Campylobacter jejuni strains from patients with Guillain-Barre syndrome. Emerging Infectious Diseases 1998 4 2 263 268 2-s2.0-0031834903
48. van Doorn P. A., Ruts L., Jacobs B. C., Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. The Lancet Neurology 2008 7 10 939 950 2-s2.0-51449103646 10.1016/S1474-4422(08)70215-1
49. Winer J. B., Guillain Barré syndrome. Journal of Clinical Pathology-Molecular Pathology 2001 54 6 381 385 2-s2.0-0035659389
50. Jacobs B. C., Schmitz P. I. M., van der Meche F. G. A., Rees J. H., Campylobacter jejuni infection and treatment for Guillain-Barre syndrome. New England Journal of Medicine 1996 335 3 208 209 2-s2.0-0029666309 10.1056/NEJM199607183350315
51. Linton D., Lawson A. J., Owen R. J., Stanley J., PCR detection, identification to species level, and fingerprinting of Campylobacter jejuni and Campylobacter coli direct from diarrheic samples. Journal of Clinical Microbiology 1997 35 10 2568 2572 2-s2.0-0030772371
52. Tsang R. S. W., The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome. Current Opinion in Infectious Diseases 2002 15 3 221 228 2-s2.0-0036099975
53. Koga M., Yuki N., Hirata K., Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroups. Acta Neurologica Scandinavica 2001 103 5 278 287 2-s2.0-0035063727 10.1034/j.1600-0404.2001.103005278.x
54. Blaser M. J., Duncan D. J., Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infection and Immunity 1984 44 2 292 298 2-s2.0-0021325693
55. Mascart-Lemone F. O., Duchateau J. R., Oosterom J., Butzler J. P., Delacroix D. L., Kinetics of anti- Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis. Journal of Clinical Microbiology 1987 25 7 1253 1257 2-s2.0-0023195388
56. Yamazaki-Matsune W., Taguchi M., Seto K., Kawahara R., Kawatsu K., Kumeda Y., Kitazato M., Nukina M., Misawa N., Tsukamoto T., Development of a multiplex PCR assay for identification of Campylobacter coli, Campylobacter fetus, Campylobacter hyointestinalis subsp. hyointestinalis, Campylobacter jejuni, Campylobacter lari and Campylobacter upsaliensis. Journal of Medical Microbiology 2007 56 11 1467 1473 2-s2.0-36448931932 10.1099/jmm.0.47363-0
57. Sivadon-Tardy V., Orlikowski D., Porcher R., Ronco E., Caudie C., Roussi J., Fauchère J.-L., Mégraud F., Tabor H., Sharshar T., Annane D., Raphaël J.-C., Gaillard J.-L., Detection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barré syndrome. Journal of Clinical Microbiology 2010 48 6 2278 2281 2-s2.0-77952919512 10.1128/JCM.00381-10
58. Bang D. D., Scheutz F., Ahrens P., Pedersen K., Blom J., Madsen M., Prevalence of cytolethal distending toxin (cdt) genes and CDT production in Campylobacter spp. isolated from Danish broilers. Journal of Medical Microbiology 2001 50 12 1087 1094 2-s2.0-0035193393
59. Honavar M., Tharakan J. K. J., Hughes R. A. C., Leibowitz S., Winer J. B., A clinicopathological study of the Guillain-Barre syndrome. Brain 1991 114 3 1245 1269 2-s2.0-0025866314
60. Christiansen J., Färm G., Eid-Forest R., Anderson C., Cederbrant K., Hultman P., Interferon- γ secreted from peripheral blood mononuclear cells as a possible diagnostic marker for allergic contact dermatitis to gold. Contact Dermatitis 2006 55 2 101 112 2-s2.0-33745903876 10.1111/j.1600-0536. 2006.00908.x
61. Kaluza W., Meyer zum Büschenfelde K.-H., Galle P. R., Märker-Hermann E., Synovial fluid lymphocyte proliferation in response to crude microbial antigens is not useful as a diagnostic test to specifically indicate a bacterial cause of arthritis. Clinical and Experimental Rheumatology 2000 18 1 39 46 2-s2.0-0033982198
62. Pichler W. J., Tilch J., The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004 59 8 809 820 2-s2.0-3442876477 10.1111/j.1398-9995.2004.00547.x
63. Valentine-Thon E., Ilsemann K., Sandkamp M., A novel lymphocyte transformation test (LTT-MELISA®) for Lyme borreliosis. Diagnostic Microbiology and Infectious Disease 2007 57 1 27 34 2-s2.0-33845437919 10.1016/j.diagmicrobio.2006.06.008
64. Nachamkin I., Allos B. M., Ho T. W., Nachamkin I., Blaser M. J., Campylobacter jejuni infection and the association with Guillain Barré syndrome. Campylobacter 2000 2nd Washington, DC, USA ASM Press 155 175
65. Winer J. B., Hughes R. A. C., Anderson M. J., Jones D. M., Kangro H., Watkins R. P. F., A prospective study of acute idiopathic neuropathy. II. Antecedent events. Journal of Neurology Neurosurgery and Psychiatry 1988 51 5 613 618 2-s2.0-0023878833
66. Wim Ang C., Jacobs B. C., Laman J. D., The Guillain-Barré syndrome: a true case of molecular mimicry. Trends in Immunology 2004 25 2 61 66 2-s2.0-0842324619 10.1016/j.it.2003.12.004
67. Shahrizaila N., Yuki N., Guillain-Barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. Journal of Biomedicine and Biotechnology 2011 2011 5 2-s2.0-79251588034 10.1155/2011/829129 829129
68. Yu R. K., Usuki S., Ariga T., Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases. Infection and Immunity 2006 74 12 6517 6527 2-s2.0-33845493421 10.1128/IAI.00967-06
69. van Belkum A., van den Braak N., Godschalk P., Ang W., Jacobs B., Gilbert M., Wakarchuk W., Verbrugh H., Endtz H., A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nature Medicine 2001 7 7 752 753 2-s2.0-0034928625 10.1038/89831
70. Ilyas A. A., Willison H. J., Quarles R. H., Jungalwala F. B., Cornblath D. R., Trapp B. D., Griffin D. R., Griffin J. W., McKhann G. M., Serum antibodies to gangliosides in Guillain-Barre syndrome. Annals of Neurology 1988 23 5 440 447 2-s2.0-0023921115
71. Press R., Deretzi G., Zou L. P., Zhu J., Fredman P., Lycke J., Link H., IL-10 and IFN- γ in Guillain-Barre syndrome. Journal of Neuroimmunology 2001 112 1-2 129 138 2-s2.0-0035213393 10.1016/S0165-5728(00)00388-X
72. Moran A. P., Annuk H., Prendergast M. M., Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. Journal of Neuroimmunology 2005 165 1-2 179 185 2-s2.0-22144468012 10.1016/j.jneuroim.2005.04.013
73. Rees J. H., Vaugham R. W., Kondeatis E., Hughes R. A. C., HLA-class II alleles in Guillain-Barre syndrome and miller fisher syndrome and their association with preceding Campylobacter jejuni infection. Journal of Neuroimmunology 1995 62 1 53 57 2-s2.0-0028810143 10.1016/0165-5728(95)00102-8
74. Hartung H.-P., Immune-mediated demyelination. Annals of Neurology 1993 33 6 563 567 2-s2.0-0027160326 10.1002/ana.410330602
75. Prasad K. N., Nyati K. K., Verma A., Rizwan A., Paliwal V. K., Tumor necrosis factor- α polymorphisms and expression in Guillain-Barré syndrome. Human Immunology 2010 71 9 905 910 2-s2.0-77956012788 10.1016/j.humimm.2010.06.013
76. Nyati K. K., Prasad K. N., Verma A., Paliwal V. K., Correlation of matrix metalloproteinases-2 and -9 with proinflammatory cytokines in Guillain-Barré syndrome. Journal of Neuroscience Research 2010 88 16 3540 3546 2-s2.0-78049437671 10.1002/jnr.22514
77. Yuki N., Yoshino H., Sato S., Miyatake T., Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990 40 12 1900 1902 2-s2.0-0025647043
78. Lisak R. P., Skundric D., Bealmear B., Ragheb S., The role of cytokines in Schwann cell damage, protection, and repair. Journal of Infectious Diseases 1997 176 6 S173 S179 2-s2.0-0030657639
79. Dahle C., Ekerfelt C., Vrethem M., Samuelsson M., Ernerudh J., T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barre syndrome. Journal of the Neurological Sciences 1997 153 1 54 60 2-s2.0-0031473251 10.1016/S0022-510X(97)00178-0
80. Ekerfelt C., Dahle C., Weissert R., Kvarnström M., Olsson T., Ernerudh J., Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis. Clinical and Experimental Immunology 2001 123 1 112 118 2-s2.0-0035142517 10.1046/j.1365-2249.2001.01424.x
81. Zhang Z., Zhang Z.-Y., Schluesener H. J., Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. Journal of Immunology 2009 183 5 3081 3091 2-s2.0-70349247894 10.4049/jimmunol.0901088
82. Chi L. J., Xu W. H., Zhang Z. W., Huang H. T., Zhang L. M., Zhou J., Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System 2010 15 4 345 356 2-s2.0-78650815791 10.1111/j.1529-8027.2010.00294.x
83. Li S., Yu M., Li H., Zhang H., Jiang Y., IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome. Mediators of Inflammation 2012 2012 7 260473 10.1155/2012/260473
84. Liang S. L., Wang W. Z., Huang S., Wang X. K., Zhang S., Wu Y., Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barré syndrome. Immunopharmacology and Immunotoxicology 2012 34 6 1039 1046 10.3109/08923973.2012.697469
85. Hartung H.-P., Toyka K. V., T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barre syndrome. Annals of Neurology 1990 27 S57 S63 2-s2.0-0025286320 10.1002/ana.410270716
86. Heininger K., Stoll G., Linington C., Toyka K. V., Wekerle H., Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines. Annals of Neurology 1986 19 1 44 49 2-s2.0-0022647857
87. Linington C., Izumo S., Suzuki M., Uyemura K., Meyermann R., Wekerle H., A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. Journal of Immunology 1984 133 4 1946 1950 2-s2.0-0021194463
88. Powell H. C., Olee T., Brostoff S. W., Mizisin A. P., Comparative histology of experimental allergic neuritis induced with minimum length neuritogenic peptides by adoptive transfer with sensitized cells or direct sensitization. Journal of Neuropathology & Experimental Neurology 1991 50 5 658 674 2-s2.0-0025815583
89. Iqbal A., Oger J. J.-F., Arnason B. G. W., Cell-mediated immunity in idiopathic polyneuritis. Annals of Neurology 1981 9 65 69 2-s2.0-0019434527
90. Korn-Lubetzki I., Abramsky O., Acute and chronic demyelinating inflammatory polyradiculoneuropathy. Association with autoimmune diseases and lymphocyte response to human neuritogenic protein. Archives of Neurology 1986 43 6 604 608 2-s2.0-0022528856
91. Hartung H.-P., Schafer B., Heininger K., Stoll G., Toyka K. V., The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations. Brain 1988 111 5 1039 1059 2-s2.0-0023692234
92. Heininger K., Schafer B., Hartung H.-P., Fierz W., Linington C., Toyka K. V., The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line. Annals of Neurology 1988 23 4 326 331 2-s2.0-0023949286
93. Baron P., Constantin G., D'Andrea A., Ponzin D., Scarpini E., Scarlato G., Trinchieri G., Rossi F., Cassatella M. A., Production of tumor necrosis factor and other proinflammatory cytokines by human mononuclear phagocytes stimulated with myelin P2 protein. Proceedings of the National Academy of Sciences of the United States of America 1993 90 10 4414 4418 2-s2.0-0027212727
94. Cammer W., Brosnan C. F., Basile C., Bloom B. R., Norton W. T., Complement potentiates the degradation of myelin proteins by plasmin: implications for a mechanism of inflammatory demyelination. Brain Research 1986 364 1 91 101 2-s2.0-0022600429
95. Cammer W., Brosnan C. F., Bloom B. R., Norton W. T., Degradation of the P0, P1, and P(r) proteins in peripheral nervous system myelin by plasmin: implications regarding the role of macrophages in demyelinating diseases. Journal of Neurochemistry 1981 36 4 1506 1514 2-s2.0-0019728939
96. Baichwal R. R., Bigbee J. W., DeVries G. H., Macrophage-mediated myelin-related mitogenic factor for cultured Schwann cells. Proceedings of the National Academy of Sciences of the United States of America 1988 85 5 1701 1705 2-s2.0-0023976002
97. Baichwal R. R., DeVries G. H., A mitogen for Schwann cells is derived from myelin basic protein. Biochemical and Biophysical Research Communications 1989 164 2 883 888 2-s2.0-0024420881
98. Lindholm D., Heumann R., Meyer M., Thoenen H., Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987 330 6149 658 659 2-s2.0-0023471275
99. Hughes R. A. C., Cornblath D. R., Guillain-Barré syndrome. The Lancet 2005 366 9497 1653 1666 2-s2.0-27644558148 10.1016/S0140-6736(05)67665-9
100. Kaida K., Kusunoki S., Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review. Journal of Neuroimmunology 2010 223 1-2 5 12 2-s2.0-77953534821 10.1016/j.jneuroim.2010.02.001
101. Wirguin I., Rosoklija G., Trojaborg W., Hays A. P., Latov N., Axonal degeneration accompanied by conduction block induced by toxin mediated immune reactivity to GM1 ganglioside in rat nerves. Journal of the Neurological Sciences 1995 130 1 17 21 2-s2.0-0028915258 10.1016/0022-510X(94)00270-X
102. Weber F., Rudel R., Aulkemeyer P., Brinkmeier H., Anti-GM1 antibodies can block neuronal voltage-gated sodium channels. Muscle & Nerve 2000 23 9 1414 1420
103. Spies J. M., Pollard J. D., Bonner J. G., Westland K. W., McLeod J. G., Synergy between antibody and P2-reactive T cells in experimental allergic neuritis. Journal of Neuroimmunology 1995 57 1-2 77 84 2-s2.0-0028986015 10.1016/0165-5728(94)00164-J
104. Zhu J., Mix E., Link H., Cytokine production and the pathogenesis of experimental autoimmune neuritis and Gulllain-Barre syndrome. Journal of Neuroimmunology 1998 84 1 40 52 2-s2.0-0032054104 10.1016/S0165-5728(97)00238-5
105. Zhu W., Mix E., Zhu J., Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats. Journal of Neuroimmunology 2003 140 1-2 97 101 2-s2.0-0037629304 10.1016/S0165-5728(03)00178-4
106. Maier H., Schmidbauer M., Pfausler B., Schmutzhard E., Budka H., Central nervous system pathology in patients with the Guillain-Barre syndrome. Brain 1997 120 3 451 464 2-s2.0-0030905473 10.1093/brain/120.3.451
107. Fox J. G., Ackerman J. I., Taylor N., Claps M., Murphy J. C., Campylobacter jejuni infection in the ferret: an animal model of human campylobacteriosis. American Journal of Veterinary Research 1987 48 1 85 90 2-s2.0-0023062008
108. Bader S. R., Kothlow S., Trapp S., Schwarz S. C. N., Philipp H.-C., Weigend S., Sharifi A. R., Preisinger R., Schmahl W., Kaspers B., Matiasek K., Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans. Journal of Neuroinflammation 2010 7, article 7 2-s2.0-77349089295 10.1186/1742-2094-7-7
109. Mäurer M., Toyka K. V., Gold R., Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models. Neuromuscular Disorders 2002 12 4 405 414 2-s2.0-0036223666 10.1016/S0960-8966(01)00302-9
110. Ang C. W., Dijkstra J. R., de Klerk M. A., Endtz H. P., van Doorn P. A., Jacobs B. C., Jeurissen S. H. M., Wagenaar J. A., Host factors determine anti-GM1 response following oral challenge of chickens with Guillain- Barré syndrome derived Campylobacter jejuni strain GB11. PloS ONE 2010 5 3, article e9820 2-s2.0-79952117123
111. Hughes R. A. C., Swan A. V., Raphaël J.-C., Annane D., van Koningsveld R., van Doorn P. A., Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 2007 130 9 2245 2257 2-s2.0-34548228508 10.1093/brain/awm004
112. Thornton C. A., Griggs R. C., Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Annals of Neurology 1994 35 3 260 268 2-s2.0-0028271671
113. Vriesendorp F. J., Dmytrenko G. S., Dietrich T., Koski C. L., Anti-peripheral nerve myelin antibodies and terminal activation products of complement in serum of patients with acute brachial plexus neuropathy. Archives of Neurology 1993 50 12 1301 1303 2-s2.0-0027139851
114. Kondo N., Ozawa T., Mushiake K., Motoyoshi F., Kameyama T., Kasahara K., Kaneko H., Yamashina M., Kato Y., Orii T., Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin. Journal of Clinical Immunology 1991 11 3 152 158 2-s2.0-0025844927
115. Pashov A., Bellon B., Kaveri S. V., Kazatchkine M. D., A shift in encephalitogenic T cell cytokine pattern is associated with suppression of EAE by intravenous immunoglobulins (IVIg). Multiple Sclerosis 1997 3 2 153 156 2-s2.0-0030865005
116. Tenser R. B., Hay K. A., Aberg J. A., Immunoglobulin G immunosuppression of multiple sclerosis: suppression of all three major lymphocyte subsets. Archives of Neurology 1993 50 4 417 420 2-s2.0-0027409418
117. Thornton C. A., Ballow M., Safety of intravenous immunoglobulin. Archives of Neurology 1993 50 2 135 136 2-s2.0-0027475961
118. Breman J. G., Hayner N. S., Guillain-Barre syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977. American Journal of Epidemiology 1984 119 6 880 889 2-s2.0-0021287973
119. Langmuir A. D., Bregman D. J., Kurland L. T., An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. American Journal of Epidemiology 1984 119 6 841 879 2-s2.0-0021260147
120. Marks J. S., Halpin T. J., Guillain-Barre syndrome in recipients of A/New Jersey influenza vaccine. Journal of the American Medical Association 1980 243 24 2490 2494 2-s2.0-0018908802 10.1001/jama.243.24.2490
121. Lasky T., Terracciano G. J., Magder L., Koski C. L., Ballesteros M., Nash D., Clark S., Haber P., Stolley P. D., Schonberger L. B., Chen R. T., The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. New England Journal of Medicine 1998 339 25 1797 1802 2-s2.0-0032542081
122. Salmon D. A., Proschan M., Forshee R., Gargiullo P., Bleser W., Burwen D. R., Cunningham F., Garman P., Greene S. K., Lee G. M., Vellozzi C., Yih W. K., Gellin B., Lurie N., H1N1 GBS Meta-Analysis Working Group. Association between Guillain-Barré syndrome and influenza A, (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. The Lancet 2013 381 9876 1461 1468 10.1016/S0140-6736(12)62189-8
123. Haber P., Sejvar J., Mikaeloff Y., DeStefano F., Vaccines and Guillain-Barré syndrome. Drug Safety 2009 32 4 309 323 2-s2.0-65949102549 10.2165/00002018-200932040-00005
124. Baxter R., Bakshi N., Fireman B., Lewis E., Ray P., Vellozzi C., Klein N. P., Lack of association of Guillain-Barré syndrome with vaccinations. Clinical Infectious Diseases 2013 57 2 197 204 10.1093/cid/cit222
125. Institute of Medicine, Adverse Effects of Vaccines: Evidence and Causality 2011 Washington, DC, USA National Academies Press
126. Souayah N., Nasar A., Suri M. F. K., Qureshi A. I., Guillain-Barre syndrome after vaccination in United States. A report from the CDC/FDA Vaccine Adverse Event Reporting System. Vaccine 2007 25 29 5253 5255 2-s2.0-34250810715 10.1016/j.vaccine.2007.03.053
127. Hemachudha T., Griffin D. E., Chen W. W., Johnson R. T., Immunologic studies of rabies vaccination-induced Guillain-Barre syndrome. Neurology 1988 38 3 375 378 2-s2.0-0023871517